Daily News Podcast

FDA approves Zephyr valves for emphysema


 

The Food and Drug Administration has approved the Zypher endobronchial valve system for patients with severs emphysema who are experiencing difficulty breathing. Also today, meth use is climbing alongside the opioid epidemic, pain remains after rheumatoid arthritis diagnosis, and higher RA biologic drug levels linked with more infections. Subscribe to the MDedge Daily News for today’s top news.

Recommended Reading

Canakinumab cut gout attacks in CANTOS
MDedge Rheumatology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Rheumatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Rheumatology
Patients going without as insulin prices skyrocket
MDedge Rheumatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Rheumatology
Opioids do more harm than good for musculoskeletal pain
MDedge Rheumatology
Adalimumab strikes out for aortic inflammation in psoriasis
MDedge Rheumatology
Addiction: Veterans with pain, opioid use disorder
MDedge Rheumatology
Medicare beneficiaries are dying differently
MDedge Rheumatology
Updated anthrax vaccine recommendations
MDedge Rheumatology